Epoxyeicosatrienoic acids - Novel mechanism and pharmacological therapy of chronic renocardiac syndrome

Hui Huang, Jie Chen, Tianxin Lin, Tong Wang, Yi Tang, Yanbin Dong, Jingfeng Wang

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Cardiorenal syndromes were defined and classified recently, but the mechanism of chronic renocardiac syndrome remains disputed. Theories about chronic renocardiac syndrome cannot offer a convincing explanation for it. As a result, the current therapies of chronic renocardiac syndrome do not contribute to a satisfied prognosis. Epoxyeicosatrienoic acids, the products of arachidonic acid metabolized by cytochrome P450 enzymes, play an important role in the maintenance of renal hemodynamics, and regulation of renal, cardiac, and vascular function with antihypertensive and anti-inflammatory properties. It is well documented that down-regulation of epoxyeicosatrienoic acids might be involved in alterations in various pathophysiological states, including hypertension, uremia and hepatorenal syndrome. Likewise, epoxyeicosatrienoic acids were reduced in heart failure and renal dysfunction. This leads to the proposed hypothesis that epoxyeicosatrienoic acids down-regulation may be the novel mechanism of chronic renocardiac syndrome. These findings suggest that manipulation of epoxyeicosatrienoic acid levels could be a novel pharmacological therapy strategy for chronic renocardiac syndrome.

Original languageEnglish (US)
Pages (from-to)550-552
Number of pages3
JournalMedical Hypotheses
Volume76
Issue number4
DOIs
StatePublished - Apr 1 2011

Fingerprint

Cardio-Renal Syndrome
Pharmacology
Acids
Kidney
Cytochrome P-450 Enzyme System
Therapeutics
Down-Regulation
Hepatorenal Syndrome
Uremia
Arachidonic Acid
Antihypertensive Agents
Blood Vessels
Anti-Inflammatory Agents
Heart Failure
Hemodynamics
Maintenance
Hypertension

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Epoxyeicosatrienoic acids - Novel mechanism and pharmacological therapy of chronic renocardiac syndrome. / Huang, Hui; Chen, Jie; Lin, Tianxin; Wang, Tong; Tang, Yi; Dong, Yanbin; Wang, Jingfeng.

In: Medical Hypotheses, Vol. 76, No. 4, 01.04.2011, p. 550-552.

Research output: Contribution to journalArticle

Huang, Hui ; Chen, Jie ; Lin, Tianxin ; Wang, Tong ; Tang, Yi ; Dong, Yanbin ; Wang, Jingfeng. / Epoxyeicosatrienoic acids - Novel mechanism and pharmacological therapy of chronic renocardiac syndrome. In: Medical Hypotheses. 2011 ; Vol. 76, No. 4. pp. 550-552.
@article{fb422008069444cb87cd8d6d83af6592,
title = "Epoxyeicosatrienoic acids - Novel mechanism and pharmacological therapy of chronic renocardiac syndrome",
abstract = "Cardiorenal syndromes were defined and classified recently, but the mechanism of chronic renocardiac syndrome remains disputed. Theories about chronic renocardiac syndrome cannot offer a convincing explanation for it. As a result, the current therapies of chronic renocardiac syndrome do not contribute to a satisfied prognosis. Epoxyeicosatrienoic acids, the products of arachidonic acid metabolized by cytochrome P450 enzymes, play an important role in the maintenance of renal hemodynamics, and regulation of renal, cardiac, and vascular function with antihypertensive and anti-inflammatory properties. It is well documented that down-regulation of epoxyeicosatrienoic acids might be involved in alterations in various pathophysiological states, including hypertension, uremia and hepatorenal syndrome. Likewise, epoxyeicosatrienoic acids were reduced in heart failure and renal dysfunction. This leads to the proposed hypothesis that epoxyeicosatrienoic acids down-regulation may be the novel mechanism of chronic renocardiac syndrome. These findings suggest that manipulation of epoxyeicosatrienoic acid levels could be a novel pharmacological therapy strategy for chronic renocardiac syndrome.",
author = "Hui Huang and Jie Chen and Tianxin Lin and Tong Wang and Yi Tang and Yanbin Dong and Jingfeng Wang",
year = "2011",
month = "4",
day = "1",
doi = "10.1016/j.mehy.2010.12.015",
language = "English (US)",
volume = "76",
pages = "550--552",
journal = "Medical Hypotheses",
issn = "0306-9877",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - Epoxyeicosatrienoic acids - Novel mechanism and pharmacological therapy of chronic renocardiac syndrome

AU - Huang, Hui

AU - Chen, Jie

AU - Lin, Tianxin

AU - Wang, Tong

AU - Tang, Yi

AU - Dong, Yanbin

AU - Wang, Jingfeng

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Cardiorenal syndromes were defined and classified recently, but the mechanism of chronic renocardiac syndrome remains disputed. Theories about chronic renocardiac syndrome cannot offer a convincing explanation for it. As a result, the current therapies of chronic renocardiac syndrome do not contribute to a satisfied prognosis. Epoxyeicosatrienoic acids, the products of arachidonic acid metabolized by cytochrome P450 enzymes, play an important role in the maintenance of renal hemodynamics, and regulation of renal, cardiac, and vascular function with antihypertensive and anti-inflammatory properties. It is well documented that down-regulation of epoxyeicosatrienoic acids might be involved in alterations in various pathophysiological states, including hypertension, uremia and hepatorenal syndrome. Likewise, epoxyeicosatrienoic acids were reduced in heart failure and renal dysfunction. This leads to the proposed hypothesis that epoxyeicosatrienoic acids down-regulation may be the novel mechanism of chronic renocardiac syndrome. These findings suggest that manipulation of epoxyeicosatrienoic acid levels could be a novel pharmacological therapy strategy for chronic renocardiac syndrome.

AB - Cardiorenal syndromes were defined and classified recently, but the mechanism of chronic renocardiac syndrome remains disputed. Theories about chronic renocardiac syndrome cannot offer a convincing explanation for it. As a result, the current therapies of chronic renocardiac syndrome do not contribute to a satisfied prognosis. Epoxyeicosatrienoic acids, the products of arachidonic acid metabolized by cytochrome P450 enzymes, play an important role in the maintenance of renal hemodynamics, and regulation of renal, cardiac, and vascular function with antihypertensive and anti-inflammatory properties. It is well documented that down-regulation of epoxyeicosatrienoic acids might be involved in alterations in various pathophysiological states, including hypertension, uremia and hepatorenal syndrome. Likewise, epoxyeicosatrienoic acids were reduced in heart failure and renal dysfunction. This leads to the proposed hypothesis that epoxyeicosatrienoic acids down-regulation may be the novel mechanism of chronic renocardiac syndrome. These findings suggest that manipulation of epoxyeicosatrienoic acid levels could be a novel pharmacological therapy strategy for chronic renocardiac syndrome.

UR - http://www.scopus.com/inward/record.url?scp=79952315682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952315682&partnerID=8YFLogxK

U2 - 10.1016/j.mehy.2010.12.015

DO - 10.1016/j.mehy.2010.12.015

M3 - Article

C2 - 21333454

AN - SCOPUS:79952315682

VL - 76

SP - 550

EP - 552

JO - Medical Hypotheses

JF - Medical Hypotheses

SN - 0306-9877

IS - 4

ER -